Literature DB >> 6997403

The role of opsonins in recovery from experimental pneumococcal pneumonia.

J C Guckian, G D Christensen, D P Fine.   

Abstract

The opsonization of type 1 and type 25 pneumococci in the rabbit lung early in the course of experimental pneumonia was studied. Bacteria washed from the lungs of animals with type 1 pneumonia were coated with IgG, IgA, and complement within 24 hr of infection; these bacteria were not phagocytized. Both type 1 and type 25 pneumococci, when incubatd in concentrates of nonimmune bronchopulmonary washings (BPC), adsorbed IgG, IgA, and C3, but neither type of pneumococci was opsonized. Killing of pneumococci by surface phagocytosis, with or without the use of nonimmune BPC, was not demonstrated. When nonimmune serum was used, opsonization of type 25 pneumococci depended on the presence of heat-labile adsorbable factors, and when immune serum and immune BPC were used, opsonization was dependent on adsorbable factors. Depletion of serum complement with cobra venom factor before infection with type 25 pneumococci resulted in severe bacteremic pneumonia in the rabbit, but immunization before complement depletion allowed animals to clear type 25 pneumococci from the blood and lungs within 24 hr. Thus, opsonization is required for efficient clearance of pneumococci from the lung, and in the nonimmune animal, complement is also required for clearance.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6997403     DOI: 10.1093/infdis/142.2.175

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  18 in total

1.  Pneumolysin-induced complement depletion during experimental pneumococcal bacteremia.

Authors:  R B Alcantara; L C Preheim; M J Gentry-Nielsen
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

2.  Standardization of an opsonophagocytic assay for the measurement of functional antibody activity against Streptococcus pneumoniae using differentiated HL-60 cells.

Authors:  S Romero-Steiner; D Libutti; L B Pais; J Dykes; P Anderson; J C Whitin; H L Keyserling; G M Carlone
Journal:  Clin Diagn Lab Immunol       Date:  1997-07

3.  Evaluation of multiplex flow cytometric opsonophagocytic assays for determination of functional anticapsular antibodies to Streptococcus pneumoniae.

Authors:  Joseph E Martinez; Elizabeth A Clutterbuck; Han Li; Sandra Romero-Steiner; George M Carlone
Journal:  Clin Vaccine Immunol       Date:  2006-04

Review 4.  The pneumococcal problem.

Authors:  S K Obaro; M A Monteil; D C Henderson
Journal:  BMJ       Date:  1996-06-15

5.  A flow cytometric opsonophagocytic assay for measurement of functional antibodies elicited after vaccination with the 23-valent pneumococcal polysaccharide vaccine.

Authors:  J E Martinez; S Romero-Steiner; T Pilishvili; S Barnard; J Schinsky; D Goldblatt; G M Carlone
Journal:  Clin Diagn Lab Immunol       Date:  1999-07

6.  Analysis of immunoglobulin isotype levels in acute pneumococcal bacteremia and in convalescence.

Authors:  K Ekdahl; J Rollof; V A Oxelius; J Engellau; J H Braconier
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-05       Impact factor: 3.267

7.  Early clearance of pneumococci from the lungs of decomplemented rats.

Authors:  S R Rehm; J D Coonrod
Journal:  Infect Immun       Date:  1982-04       Impact factor: 3.441

8.  Immunogenic properties in mice of hexasaccharide from the capsular polysaccharide of Streptococcus pneumoniae type 3.

Authors:  H Snippe; A J van Houte; J E van Dam; M J De Reuver; M Jansze; J M Willers
Journal:  Infect Immun       Date:  1983-06       Impact factor: 3.441

9.  Bactericidal versus bacteriostatic antibiotic therapy of experimental pneumococcal meningitis in rabbits.

Authors:  W M Scheld; M A Sande
Journal:  J Clin Invest       Date:  1983-03       Impact factor: 14.808

10.  Comparative role of complement in pneumococcal and staphylococcal pneumonia.

Authors:  J D Coonrod; K Yoneda
Journal:  Infect Immun       Date:  1982-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.